Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.
Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, Jiang W, Luu HH, Vanichakarn P, Szatkowski JP, Park JY, Breyer B, He TC.
Zhou L, et al. Among authors: he tc.
Cancer Lett. 2003 Apr 25;193(2):161-70. doi: 10.1016/s0304-3835(03)00013-2.
Cancer Lett. 2003.
PMID: 12706873
Free PMC article.